Lung Adenocarcinoma Originates from Retrovirus Infection of Proliferating Type 2 Pneumocytes during Pulmonary Post-Natal Development or Tissue Repair


Published in the journal: . PLoS Pathog 7(3): e32767. doi:10.1371/journal.ppat.1002014
Category: Research Article
doi: 10.1371/journal.ppat.1002014

Summary

Jaagsiekte sheep retrovirus (JSRV) is a unique oncogenic virus with distinctive biological properties. JSRV is the only virus causing a naturally occurring lung cancer (ovine pulmonary adenocarcinoma, OPA) and possessing a major structural protein that functions as a dominant oncoprotein. Lung cancer is the major cause of death among cancer patients. OPA can be an extremely useful animal model in order to identify the cells originating lung adenocarcinoma and to study the early events of pulmonary carcinogenesis. In this study, we demonstrated that lung adenocarcinoma in sheep originates from infection and transformation of proliferating type 2 pneumocytes (termed here lung alveolar proliferating cells, LAPCs). We excluded that OPA originates from a bronchioalveolar stem cell, or from mature post-mitotic type 2 pneumocytes or from either proliferating or non-proliferating Clara cells. We show that young animals possess abundant LAPCs and are highly susceptible to JSRV infection and transformation. On the contrary, healthy adult sheep, which are normally resistant to experimental OPA induction, exhibit a relatively low number of LAPCs and are resistant to JSRV infection of the respiratory epithelium. Importantly, induction of lung injury increased dramatically the number of LAPCs in adult sheep and rendered these animals fully susceptible to JSRV infection and transformation. Furthermore, we show that JSRV preferentially infects actively dividing cell in vitro. Overall, our study provides unique insights into pulmonary biology and carcinogenesis and suggests that JSRV and its host have reached an evolutionary equilibrium in which productive infection (and transformation) can occur only in cells that are scarce for most of the lifespan of the sheep. Our data also indicate that, at least in this model, inflammation can predispose to retroviral infection and cancer.

Introduction

Retroviruses have been instrumental in understanding the genetic basis and the fundamental molecular mechanisms leading to cancer [1]. Studies on the pathogenesis of retrovirus induced malignancies have also contributed to our understanding of the cells that give origin to cancer and the role played by stem and progenitor cells in these processes [2]. The “cancer stem cell” (CSC) hypothesis postulates that cancer is initiated and sustained by adult stem cells [3][4]. A growing body of experimental evidence is supporting the presence of CSCs in haematological malignancies and in some solid tumours. However, the presence and significance of CSCs is object of considerable debate particularly in slow turnover organs such as the lungs [5][7]. Identifying the cells that give origin to cancer is critical both to understand the basic carcinogenetic processes but also to devise appropriate therapeutic strategies.

Most retroviruses induce transformation of hematopoietic cells but there are a few notable exceptions causing sarcomas, nephroblastomas, mammary carcinomas, nasal and lung adenocarcinomas in a variety of animal species [8]. Ovine pulmonary adenocarcinoma (OPA) is a naturally occurring (and experimentally inducible) lung cancer of sheep caused by a retrovirus known as Jaagsiekte sheep retrovirus (JSRV) [9][11]. OPA is a common disease of sheep in most geographical areas of the world. Interestingly, the disease shares several clinical and histological features with some forms of human lung adenocarcinomas. Therefore, OPA represents an excellent animal model with great potential to contribute significantly to our understanding of retroviral pathogenesis, lung tumorigenesis and pulmonary biology [9], [12][13].

JSRV is the only oncogenic virus that causes a naturally occurring lung adenocarcinoma. Interestingly, in contrast to the overwhelming majority of oncogenic retroviruses, JSRV is a replication-competent virus that possesses a structural protein (the viral envelope, Env) that acts as a dominant oncoprotein [14][16]. Expression of the JSRV Env is sufficient to induce cell transformation in vitro in a variety of cell lines [13][15], [17][22] and importantly in vivo in both experimental mice models and in lambs [23][24]. Thus, productive virus infection and cell transformation are mutually dependent in OPA and this creates an “evolutionary dilemma” as, at face value, abundant viral replication is entirely dependent on tumor development in the host. The JSRV Env is believed to induce cell transformation via the activation of a variety of signal transduction pathways including the PI-3K/Akt and Ras-MEK-MAPK [13], [20], [22],[25][27].

Experimentally, intratracheal inoculation of concentrated JSRV viral particles in young lambs induces OPA in the overwhelming majority of animals with a very short incubation period (varying from a few weeks to a few months) [28][29]. There is a clear age-dependent susceptibility to experimentally induced OPA in lambs while it is not possible (or extremely difficult) to reproduce the disease in adult sheep [29]. These data suggest that there is a different availability of the target cells of JSRV transformation in animals of a different age. The age-susceptibility to OPA induction does not appear to be related to expression of the receptor in target cells or to a differential immune response towards the virus. Indeed, the cellular receptor for the virus (Hyaluronidase-2, Hyal-2) is ubiquitously expressed [16], [29] and this virus can infect several cell types in vitro and in vivo [30][33]. In addition, JSRV naturally or experimentally-infected animals do not mount a significant immune response, likely as a result of tolerance induced by expression of JSRV-related endogenous retroviruses (enJSRVs) which are present in the genome of all domestic and wild sheep [34][37].

In OPA affected sheep, abundant expression of JSRV proteins are confined to the tumor cells although viral RNA and DNA can be detected by sensitive PCR assays in a variety of cells of the lymphoreticular system [30][31], [38]. In sheep naturally infected with JSRV and with no neoplastic lesions, JSRV can be detected only in lymphoid tissues [39]. OPA tumours, similar to some human lung adenocarcinomas, are formed by secretory cells of the distal pulmonary tract; predominantly alveolar type 2 pneumocytes and less commonly the non-ciliated bronchial cells of the terminal bronchioli (Clara cells; see note at the end of the text on the usage of this term) [40][42]. Interestingly, a putative bronchioalveolar stem cell (BASC) has been identified in mice lungs although its presence in other species, including humans, has not been established with certainty [43]. It has been proposed that BASCs have the capacity to originate both Clara cells and type 2 pneumocytes and to be the cell origin of lung adenocarcinoma in mice in response to oncogenic K-ras [43]. However the significance of BASCs in physiological and pathological processes and the origin of lung adenocarcinoma are under debate [44][45].

In order to identify the target cells of JSRV infection and transformation we performed a series of in vivo studies in experimentally infected lambs and adult sheep. Furthermore, we derived a JSRV-based vector in order to assess the ability of this virus to infect non-dividing cells in vitro. In this study we identified the cells target of JSRV infection and transformation and provide important insights into lung biology, pulmonary carcinogenesis and retroviral pathogenesis.

Methods

Ethics statement

All experimental procedures carried out in this study are included in Project Licence 60/3905 approved by the Home Office of the United Kingdom in accordance to the “animals (scientific procedures) act 1986”. Experiments carried out at the Istituto G. Caporale were also detailed in protocol number 3315 approved by the Italian Ministry of Health (Ministero della Salute) in accordance with Council Directive 86/609/EEC of the European Union.

Virus stock preparation

Viral stocks used in all these experiments were produced in rat 208F.JSRV21 cells as already described [46]. Briefly, 208F.JSRV21 derive from 208F cells [47] stably transfected with a plasmid expressing the JSRV21 infectious molecular clone [11]. 208F.JSRV21 cells were plated at 80% confluence and supernatants were collected after 24, 48 and 72 h. Virus was concentrated by ultracentrifugation [300×] as previously described [11] and resuspended in 1×TNE buffer (100mM NaCl, 10 mM Tris, 1 mM EDTA). The infectious titer for JSRV cannot be easily calculated in vitro, because of the lack of a convenient tissue culture system for this virus. In order to infect animals with the same amount of JSRV, pellets from various virus preparations were pooled into a single stock, divided into 1 ml aliquots and stored at −80°C until use. In all the experiments described below, each animal received the same amount of virus stock. In a related study, the same JSRV preparation used here, induced OPA in 4 of 4 experimentally infected lambs within 5 months after inoculation (Caporale and Palmarini, unpublished).

In vivo studies

Animal studies were performed at the Istituto G. Caporale (Teramo, Italy) and at the University of Glasgow. Prior to experimental infections all animals were anaesthetised with sodium pentobarbital anesthesia, and all efforts were made to minimize suffering. To facilitate the detection of infected cells, JSRV (1 ml) was inoculated directly into the accessory bronchus of the cranial lobe of the right lung by fiber-optic bronchoscopy. Sheep used in this study were females between 3 and 5 year old of either bergamasca cross-breed (study 1, 2 & 4) or blackface breed (study 3) unless otherwise indicated. Three independent studies were performed as follow.

Study 1: Age related susceptibility to JSRV infection

Four 2-day old lambs and 4 adult sheep were anesthetized and inoculated with JSRV, as described above. Two animals were used as mock inoculated controls. Ten days post infection animals were euthanized, the lungs removed from the thoracic cavity and examined for the presence of macroscopic lesions. Samples from respectively 8 (in lambs) and 16 (in sheep) regions from the cranial lobe were collected and fixed overnight in 10% buffered formalin and embedded in paraffin. Tissue sections were examined by immunohistochemistry and immunofluorescence as described below.

Study 2: Bronchioalveolar proliferation in lambs and adult sheep

Lung tissues were collected at post-mortem from adult sheep (n = 2) and 4 lambs (2–4 day old). Tissues were collected from 4 different lobes of the lungs and fixed overnight in 10% buffered formalin. Tissues were examined for bronchiolar alveolar cell proliferation from ten sections from each animal as described below.

Study 3: Induction of mild lung injury in adult sheep

Mild lung injury was induced in adult sheep using 3- methylindole (3MI, Sigma). Four adult sheep were divided in two groups. All animals were weighted and fasted 12 hours before dosing. Group 1 received 0.25 g/kg body weight of 3MI (Sigma) dissolved in 50 ml of corn oil (Sigma) and administrated using a stomach tube attached to a syringe. Group II served as control and received a similar amount of corn oil. After 48 hours all animals were euthanized and lung tissue were collected for histological and immunofluorescence analysis to assess the injury and cell proliferation.

Study 4: Infection of adult sheep with or without lung injury

Ten adult sheep were divided in two groups of 5 animals each. Group 1 received 0.25 g 3MI/kg body wt as described above. Group 2 served as control and received a similar amount of corn oil. After 48 h all animals from group 1 and 2 were infected with JSRV as described above and euthanized 10 days post-infection. Samples of lung tissues were collected at post-mortem and processed as above.

Naturally occurring OPA tumour samples

Formalin-fixed, paraffin-embedded OPA tumour samples from naturally occurring (n = 6) and experimentally induced (n = 2) cases were obtained from the Department of Veterinary Pathology, University of Zaragoza. All tumour samples were previously diagnosed as JSRV positive by immunohistochemistry as already described [23], [38], [48]. Four serial sections for each tumour were analysed by immunofluorescence as described below.

Immunofluorescence and immunohistochemistry

Tissue sections were deparaffinised and hydrated using standard procedures. Antigen retrieval was performed using citrate buffer (pH6) and pressure cooker heating. To quench endogenous peroxidase, sections were incubated in 3% H2O2 diluted in methanol or PBS for 30 minutes. Sections were incubated overnight at 4°C with the following primary antibodies: polyclonal rabbit anti pro-SP-C (Seven Hills Bioregagents or Chemicon, dilution 1∶4000), monoclonal mouse anti Ki67 (DAKO, 1∶2000), mouse monoclonal anti JSRV Env (1∶200, kindly provided by Dusty Miller) [24], [49]. For CC10 detection we used either a polyclonal rabbit (Proteintech) or mouse (Dundeecell products) antisera generated against full length recombinant bovine CC10. Mouse CC10 was detected using goat anti-mouse CC10 clone T18 (Santa Cruz; 1∶200). Immunofluorescence detection was performed using the following labelled secondary antibodies: goat anti-mouse Alexa488, donkey anti-rabbit Alexa-555, donkey anti-rabbit Alexa 488. SP-C was detected using horseradish peroxidase (HRP)-conjugated donkey anti-rabbit secondary antibody (1∶6000) by tyramide signal amplification (TSA; Perkin-Elmer Life Science Products) while Ki67 was detected using donkey anti-mouse Alexa488 or Alexa-555. Slides were mounted with medium containing DAPI (Vectashield; Vector Laboratories). Immunohistochemistry was performed with Dako supervision system (DAKO) and slides were counterstained with haematoxylin. Confocal images were analysed and merged using Image-pro analyser 7 software (MediaCybernetics). Histological images were captured using cell∧D software (Olympus). Proliferation analysis was performed by counting SP-C/Ki67 double positive cells in the entire 10 lung sections for each animal using a Leica TCS SP2 confocal microscope. Numbers of double positive cells were normalized to the sectioned area using Image-pro analyser 7 Software. Bronchiolar cell proliferation was determined by counting the number of CC10+/Ki67+ cells in 100 terminal bronchioli for each animal.

Plasmids

The JSRV-based vector employed in this study was derived from the JSRV21 infectious molecular clone pCMV2JS21 [11] and was termed pCJS-EfGFP-mC. Most of the JSRV gag and pol have been deleted and replaced by a cassette containing the promoter of the human elongation factor 1 α (EF1α) driving the enhanced green fluorescent protein (eGFP). The EF1α-eGFP cassette was derived from pDRIVE5-GFP-3 (InvivoGen). In addition, pCJS-EfGFP-mC also contains the woodchuck hepatitis post-transcriptional regulatory element (WPRE; before the env splice acceptor) [50][51] derived from pCCLcPPTPGKEGFPLTRH1shSOD1 (Addgene Inc.). In pCJS-EfGFP-mC, the JSRV env has also been deleted and replaced with the cDNA expressing the mCherry fluorescent protein, followed by two copies of the Mason-Pfizer constitutive transport element (CTE) [52][53]. The packaging plasmid pCMVGPP-MX-4CTE expresses the JSRV Gag, Pro and Pol genes and derives from plasmid pGPP-MX by the addition of 3 additional CTE copies. pGPP-MX has been already described [23]. pCMV-SX2.JS-env expresses the JSRV Env under the control of the CMV immediate early promoter and was derived from the pSX2.Jenv (a gift by Dusty Miller) [33], [54]. pCDNA3-HA-Sam68 is an expression plasmid for the RNA binding protein Sam68 and was a gift from David Shalloway [55]. Plasmids pCSGW-GFP (HIV-based vector), p8.2 and pMD.G have been described previously [56].

Cells

293T cells and sheep choroid plexus (SCP) cells were grown in Dulbecco's modified Eagle's medium and Iscove's modified Dulbecco's medium respectively supplemented with 10% fetal bovine serum at 37°C, with 5% CO2 and 95% humidity.

JSRV vector production

Particles of a JSRV-based viral vector (JS-EeGFP-mCherry) were produced by co-transfecting 293T cells with pCJS-EfGFP-mC, pCMVGPP-MX-4CTE, pCMV-SX2.JS-env and pCDNA3-HA-Sam68 plasmids essentially as described previously [23]. Viral particles were collected from supernatants of transfected cells, 24 and 48 h post-transfection, filtered through 0.45 µm filters (Millipore) and concentrated [200×] by ultracentrifugation as described previously [23]. A lentiviral vector (HIV-GFP) was used as control and prepared exactly as above by co-transfecting 293T cells with pCSGW-GFP, p8.2 and pMD.G.

In vitro vector transduction

Target cells synchronization was established by culturing SCP cells in the presence of 0.2% fetal bovine serum (FBS) for 72 h. Synchronized SCP cells were then seeded at 5×104 cells/well in 6 well plates and treated for 25 h with 5 µg aphidicolin (Sigma). Target cells were infected with serial dilutions of the JSRV or HIV-based vector in presence of polybrene [57], [58]. Transduction controls included infection with heat-treated vector preparations (65°C/30′). 12 h post-infection, cells were washed three times with phosphate-buffered saline and incubated for further 48 h in the presence or absence of aphidicolin. Viral titers were expressed as fluorescence forming foci/ml and were determined by counting foci of GFP positive cells 48 h post-infection. Cellular DNA content was determined by staining cells with 7-Aminoactinomycin D (7AAD, Invitrogen) and measuring fluorescence in a Beckman Coulter flow cytometer. SCP cells were harvested by trypsinization and incubated for 1 h with 25 µg/ml 7AAD, 0.03% saponin (Sigma) and 1% BSA (Sigma). Cells were then transferred in 500 µl of 1×PBS and the proportion of cells in G0/G1, S and G2/M phases was estimated using expo32 software (Beckman Coulter) and counting 20000 events.

Results

Phenotype of naturally occurring OPA tumours

Ultrastructural, histological and immunophenotyping studies have shown that OPA tumours, similarly to some forms of human adenocarcinomas, are formed by type 2 pneumocytes and to a lesser extent by Clara cells [40], [42], [59][62]. No data are available in the literature on whether JSRV is expressed in both these cell types in the OPA tumours.

Here, we analysed by immunofluorescence and confocal microscopy serial tumor sections collected from six sheep with late stages of naturally occurring OPA and two lambs with experimentally induced disease, in order to characterize both the phenotype of the cells forming the neoplasm and viral expression. Type 2 pneumocytes and Clara cells can be easily identified by the expression of surfactant protein-C (SP-C) and the Clara cell 10 protein (CC10) respectively [63][64]. As expected, our confocal microscopy analysis revealed that all the neoplastic foci were composed mainly by SP-C+ cells (Fig. 1). In all cases the SP-C+ cells co-expressed the JSRV Env that was localized mainly at the apical surface of the cell (Fig. 1A–C). Despite multiple optical serial section (z stacks images) were analysed for each section, we found that the majority of tumor lesions were formed by cells that did not express CC10 (Fig. 1D). Areas with CC10+ cells were detected in 2 of the 6 natural OPA tumours analyzed. However, in both of these cases CC10+ positive cells did not show clear expression of the JSRV Env (Fig. 1E–F).

Phenotype of tumor cells in naturally occurring OPA.
Fig. 1. Phenotype of tumor cells in naturally occurring OPA.
Immunofluorescence of lung tumor sections from sheep affected by OPA. Panel A–C show tumor sections analyzed by confocal microscopy using antibodies towards SP-C (showed in red), the JSRV Env (showed in green) and the appropriate secondary antibodies as described in Materials and Methods. Panels D–F show tumor sections analyzed by confocal microscopy using antibodies towards CC10 (showed in red), and the JSRV Env (showed in green). Nuclei were stained with DAPI and are shown in blue. Arrows in panel E indicates a CC10+ cells where JSRV Env expression is not detectable. The insert in panel E shows a larger magnification of the area indicated by the arrows. Scale bars: A,F = 75 µm, B = 43 µm, C = 34 µm, D = 89 µm, E = 29 µm.

Age susceptibility to JSRV infection and transformation

Experimentally, OPA can be easily induced in lambs but not in adults [28][29], [65]. The incubation period of experimentally induced OPA is directly related to the age of the infected animals [29]. These data can be explained by hypothesizing a differential abundance of the cell targets for viral infection in lambs compared to adult sheep. Alternatively, the target cells for JSRV infection may be present both in lambs and in adults but only in the former, infection is able to progress to neoplastic transformation. In order to begin to address this issue we experimentally infected four newborn lambs and four adult sheep with JSRV and analysed virus-infected cells 10 days post-infection.

Virus was inoculated directly in the accessory bronchus via bronchoscopy in order to facilitate subsequent detection (Fig. 2A). Animals were euthanized 10 days post-infection and lung samples collected from either 8 (in lambs) or 16 (in adult sheep) regions of the cranial lobe of the lungs to maximise the chances of detecting a small number of virus infected cells and in order to compensate the differences in size between the lambs and adult lungs.

JSRV infection in lambs and adult sheep.
Fig. 2. JSRV infection in lambs and adult sheep.
(A) Schematic diagram of the sheep lungs. Experimental inoculations were performed administering JSRV by bronchoscopy directly into the accessory bronchus. Tissue samples (1 for each lamb and 2 for each adult sheep) were collected from eight areas (delimited by red lines dotted lines in the panel) of the right cranial lobe. (B) Graph showing the mean number of JSRV Env+ clusters per animal as detected by immunohistochemistry in four lambs and four adult sheep (error bars indicate ± SD) 10 days post-infection. (C–E) Immunohistochemistry of JSRV Env+ cells in lung sections of adult sheep (C) and lambs (D–E) 10 days post infection. Env expression (characterized by the intra cytoplasmic dark brown colour) was detected in all experimentally infected lambs but not in adult sheep. (F–I) Phenotype of JSRV infected cells in experimentally infected lambs after 10 day post-infection. Panels F–G show lung sections analyzed by confocal microscopy using antibodies towards SP-C (showed in red) and the JSRV Env (showed in green). Nuclei were stained with DAPI and are shown in blue. Arrows indicate JSRV Env+ cells. Panel H–I show lung sections analyzed by confocal microscopy using antibodies towards CC10 (showed in red) and the JSRV Env (showed in green). Inserts show a larger magnification of the area indicated by the arrows. Scale bars in C = 200 µm; D–E = 100 µm; F–G = 47 µm; H = 30 µm; H = 75 µm.

We detected JSRV infected cells by immunohistochemistry using monoclonal antibodies against the viral Env [24], [49]. We were not able to detect any JSRV-infected cells in all the sections derived from the adult sheep used in this experiment (Fig. 2B–C). In contrast, all sections analyzed from each lamb showed JSRV-infected cells (Fig. 2B, D–E). On average, in each lamb we detected 32 clusters of JSRV infected cells ranging in size from 1 to 36 cells (mean 4.9±6.5) with some of them clearly displaying a neoplastic phenotype. Overall these data strongly suggest that the age related susceptibility to OPA is due to the ability of JSRV to infect cells that are much more abundant in the lungs of lambs compared to adult sheep.

We then characterized the phenotype of viral infected cells in the lungs of experimentally infected lambs. We analyzed by immunofluorescence and confocal microscopy lung sections incubated with both antibodies towards SP-C or CC10 and the JSRV Env. In all cases, JSRV Env+ cells were also SP-C+ (Fig. 2F, G). We were not able to detect any JSRV Env+ cell that was also CC10+. Some early neoplastic lesions were observed in the respiratory bronchioli but in these cases they were always CC10 negative (Fig. 2H–I). Overall, the data obtained in experimentally infected lambs at the early stages of viral infection are in accordance with the observations made in naturally occurring OPA cases and indicate that cells of the type 2 pneumocytes lineage are infected and transformed by JSRV.

Age-dependent susceptibility to JSRV infection correlates with the presence of proliferating type 2 pneumocytes

So far, our results showed that lambs are more susceptible to experimentally induced OPA due to the ability of the virus to infect type 2 pneumocytes in lambs but not in adults. Obviously, mature type 2 pneumocytes are present abundantly both in lambs and adults. Therefore, we reasoned that JSRV was able to infect a sub-population of SP-C+ that was abundantly present in lambs but not in adult sheep. The normal developed lung is a relatively quiescent organ, with low levels of cell division in the bronchioalveolar epithelium [66]. For a variety of mammals, lungs are not yet mature at birth but continue to develop during a period (“alveolar” stage) where the number of alveoli increases dramatically [67][68]. Thus, we hypothesised that JSRV infected lung alveolar proliferating cells instead of post-mitotic type 2 pneumocytes. In order to test this hypothesis, we first analysed by immunofluorescence the mitotic status of type 2 pneumocytes and Clara cells in lambs and adults sheep lungs using antibodies towards the proliferation marker Ki67 [69] in conjunction with either antisera towards SP-C or CC10 (Fig. 3). We found that proliferating type 2 pneumocytes (SP-C+/Ki67+), addressed here as lung alveolar proliferating cells (LAPCs), were up to 50 times more abundant in newborn lambs compared to adult sheep (p<0.001) (Fig. 3A–B). Also proliferating Clara cell (CC10+/Ki67+) in the terminal bronchioli were more abundant in lambs compared to adult sheep. We detected 94.5±39 CC10+/Ki67+ per 100 terminal bronchioli in lambs while there were only 5.5±2.1 CC10+/Ki67+ per 100 terminal bronchioli in adult sheep (p = 0.004) (Fig. 3C–D).

Number of proliferating SP-C<sup>+</sup> and CC10<sup>+</sup> cells in healthy lambs and adult sheep.
Fig. 3. Number of proliferating SP-C+ and CC10+ cells in healthy lambs and adult sheep.
(A) Analysis of proliferating type 2 pneumocytes was performed by counting SP-C/Ki67 double positive cells in 2–4 day-old lambs (n = 4) and adult sheep (n = 2) by confocal microscopy as described in Materials and Methods. 10 sections for each animal were analysed using by confocal microscopy and numbers of double positive cells were normalized to the sectioned area. Results shown are the average numbers of SP-C+/Ki67+ (± SD) per section for both groups of animals. (B) Representative image of a lung section from a 2 day old lamb analyzed by confocal microscopy using antibodies towards SP-C (showed in red) and Ki67 (showed in green). Nuclei were stained with DAPI and are shown in blue. Note that Ki67 is a nuclear marker and therefore positive signal appears in turquoise in the merged image. Arrows indicate SP-C+/Ki67+ cells. (C) Analysis of proliferating Clara cells was performed by counting the number of CC10+/Ki67+ cells in 100 terminal bronchioli per each animal as indicated in Panel A. Results shown are the average numbers of CC-10+/Ki67+ (± SD) per 100 terminal bronchioli for both groups of animals. (D) Representative image of a lung section from a 2 day old lamb analyzed by confocal microscopy using antibodies towards CC-10 (showed in green) and Ki67 (showed in red). Nuclei were stained with DAPI and are shown in blue. Arrows indicate CC-10+/Ki67+ cells.

A subset of SP-C+/CC10+ putative pulmonary stem cells (known as bronchioalveolar stem cells or BASCs) was identified at the bronchioalveolar junction in mice [43]. We analysed the localization of the proliferating Clara cells in the terminal bronchioli of lambs and sheep and found that they were not localised in a specific area of the terminal bronchioli but randomly distributed. In addition, we could not detect SP-C+/CC-10+ double-positive cells by confocal microscopy in either lambs or adult sheep, while we were able to identify cells with this phenotype in mice (Fig. S1).

Lung injury renders adult animals susceptible to JSRV infection and transformation

So far our data suggested that the presence of LAPCs in lambs is the main factor determining the susceptibility of young animals to JSRV infection as opposed to the resistance observed by adult sheep. Indeed, in the adult lungs, the proliferation rate of the respiratory epithelium is very low [68]. However, the lung has a significant reparative capability and after an injury the LAPC proliferate and play an important role in the tissue regenerative process. We therefore reasoned that we would be able to render adult sheep susceptible to experimental JSRV infection by previous induction of a mild lung injury that would stimulate LAPCs. 3MI is an organ-selective pneumotoxicant that affects specifically type I pneumocytes and bronchiolar epithelial (Clara) cells and it is especially effective in ruminants [69], [70]. Here, to assess the ability of 3MI to induce lung injury and repair we exposed two sheep to this pneumotoxicant and we then assessed lung injury after 48 hours. Histological examination showed diffuse pulmonary edema with scattered hemorrhagic foci (Fig. 4A–B). Next, we assessed the proliferation status of type 2 pneumocytes and Clara cells by verifying co-expression of SP-C or CC10 with the proliferating marker Ki67 by immunofluorescence as described above (Fig. 4C–F). The number of SP-C+/Ki67+ cells was 90 fold higher in sheep after lung injury as opposed to normal control sheep (p<0.001) (Fig. 4H). The examination of the terminal bronchioli in sheep after 3MI administration revealed that almost 100% of terminal bronchioli contained CC10+/Ki67+ (Fig. 4G). The total number of CC10+/Ki67+ cells was more than 100 fold higher in adult sheep after lung injury compared to healthy controls (p = 0.009) (Fig. 4H). Also in adult sheep after lung injury we were not able to identify any SP-C+/CC10+ double-positive cells (data not shown).

Mild lung injury model in adult sheep.
Fig. 4. Mild lung injury model in adult sheep.
(A–B) Histology of lung sections of sheep treated with 3 methylindole (3MI) (A) and mock-treated controls (B). Treatment with 3MI is characterized by edema and haemorrhagic areas. (C–D) Representative images of lung sections from adult sheep treated with 3MI (C) or mock control (D) analyzed by confocal microscopy using antibodies towards CC10 (showed in green) and Ki67 (showed in red) and the appropriate fluorescent conjugates as described in Materials and Methods. Nuclei were stained with DAPI and are shown in blue. Note in panel C the extensive injury of bronchiolar epithelium (absence of CC10 staining) and proliferation of toxicant resistant Clara cell progenitors (indicated by arrows). Note in both panels C and D the terminal bronchioli (Tb). (E–F) Representative images of lung sections from adult sheep treated with 3MI (E) or mock-treated (F) analyzed by confocal microscopy using antibodies towards SP-C (showed in red) and Ki67 (showed in green). Note in panel E the presence of several SP-C+/Ki67+ cells. Nuclei were stained with DAPI and are shown in blue. Arrows indicate SP-C+/Ki67+ cells. (G) Graph representing the quantification of the data analysed by confocal microscopy. Results shown are the average numbers of SP-C+/KI-67+ (± SD) per section for both groups of animals. (H) Analysis of proliferating Clara cells was performed by counting the number of CC10/Ki67 double-positive cells in 100 terminal bronchioli per each animal. Results shown are the average numbers of CC-10+/Ki67+ (± SD) per 100 terminal bronchioli for both groups of animals. Scale bars, A–B = 200 µm; E–F = 47 µm; C–D = 89 µm.

Overall, the data presented above indicate that the number of LAPCs, that we identified as target cells of JSRV infection, increase dramatically after mild lung injury. In order to determine whether lung injury may render adult sheep susceptible to JSRV infection, we treated five sheep with 3MI and after 48 h we infected them with JSRV (Group I). Five additional sheep were infected with JSRV without pre-treatment with 3MI (Group II). 10 days after infection animals were euthanized (Fig. 5A). As expected, post-mortem examination revealed no signs of lesions attributed to lung injury. In each animal, the presence of JSRV infection was assessed in 15 sections collected from the cranial lobe by immunohistochemistry. JSRV Env expression was only detected in lung cells of animals that were infected after treatment with 3MI (Fig. 5B, D–F). On average, 10 clusters of JSRV Env+ cells (ranging from 1 to 80 cells) were detected in each animal while no JSRV infected cell was detected in those animals that were infected without 3MI pre-treatment (Fig. 5C).

Induction of mild lung injury renders adult sheep susceptible to JSRV infection.
Fig. 5. Induction of mild lung injury renders adult sheep susceptible to JSRV infection.
(A) Schematic diagram of the study design. Ten adult sheep were randomly allocated in two groups. Sheep in Group I (red bar) were dosed 3MI (red arrow) as described in Materials and Methods while Group II served as control. After 2 days all animals in both groups were infected with JSRV (black arrow) and euthanized 10 days post infection. (B) Graph showing the mean number of JSRV Env+ clusters per animal as detected by immunohistochemistry in sheep of Group I and Group II 10 days post-infection (± SD). (C) Graph showing the number of cells forming each cluster of JSRV Env+ cells in sheep of Group I. (D–F) Immunohistochemistry of lung sections of adult sheep of group II (D) and group I (E–F, pre-treated with 3MI before JSRV infection) 10 days post-infection as described in Materials and Methods. Env expression (characterized by the intra cytoplasmic dark brown colour) was detected in sheep of Group I but not in sheep of Group II. Scale bars, D = 200 µm; E–F = 100 µm.

By immunofluorescence and confocal microscopy we found that all JSRV infected cells were SP-C positive (Fig. 6A–C). None of the JSRV Env+ cells were CC10+ (Fig. 6D–F), despite the high number of proliferating Clara cells induced by 3MI and the presence of numerous infected cells localized in the terminal bronchioli.

Phenotype of JSRV infected cells in adult sheep with lung injury.
Fig. 6. Phenotype of JSRV infected cells in adult sheep with lung injury.
Representative images of lung sections from adult sheep pre-treated with 3MI before experimental JSRV infection. (A–C) Sections were analyzed by confocal microscopy using antibodies towards SP-C (showed in red) and the JSRV Env (showed in green). Nuclei were stained with DAPI and are shown in blue. Arrows indicate autofluorescent red blood cells (RBC). (D–F) Sections analyzed as above using antibodies towards CC10 (showed in red) and the JSRV Env (showed in green). Nuclei were stained with DAPI and are shown in blue. Scale bars, A–B = 47 µm; C = 89 µm; D = 26 µm; E = 33 µm and F = 25 µm.

JSRV preferentially infects dividing cells in vitro

Our data have shown that JSRV infects LAPCs but not the overwhelming majority of type 2 pneumocytes which divide very slowly. These data could be explained mechanistically by the fact that the majority of retroviruses, with the exception of lentiviruses [71], infect more efficiently cells that are in mitosis [72][73]. The proliferation rate of type 2 pneumocytes is very low in adults under normal conditions. On the other hand the higher proliferative rate of LAPCs during post-natal development or tissue repair in the adult would facilitate JSRV infection. Experiments with JSRV in vitro are hindered by the lack of a convenient tissue culture system for the propagation of this virus [32]. Therefore, we constructed a convenient JSRV-derived viral vector (JS-EeGFP-mCherry) in order to easily quantify JSRV infection in proliferating and non-proliferating cells. JS-eGFP-mCherry was derived by transiently transfecting 293T cells with (i) a packaging plasmid (pGPP-MX-4CTE) devoid of the JSRV packaging signal (Ψ) and expressing the viral Gag, Pro and Pol; (ii) a plasmid providing the JSRV Env in trans (pC-ML-JSenv, also devoided of Ψ), and (iii) the packaged JSRV vector (pCJS-EFGFP-MC) that upon infection and integration expresses eGFP under the control of an internal promoter (Fig. 7A). JS-eGFP-mCherry viral particles were then used to infect synchronized SCP cells in the presence or absence of a drug that, at the concentration used in this study, arrests cells in the G1 phase (aphidicolin) (Fig. 7B). Consistently, JS-eGFP-mCherry was able to transduce actively dividing SCP cells approximately 200 times more efficiently (p = 0.002) than the same cells where mitosis was arrested with aphidicolin while only minor differences between treated and untreated cells were observed with the lentivirus vector HIV-GFP (Fig. 7C).

Infectivity of JSRV in proliferating and mitotic arrested cell.
Fig. 7. Infectivity of JSRV in proliferating and mitotic arrested cell.
(A) Schematic representation of the experimental design. A JSRV-based vector was derived by transfecting 293T with pJS-EFGFP-MC, pGPP-MX-4CTE and pC-MLV-JSenv as described in the materials and methods. The resulting vector, JS-eGFP, was then used to infect synchronized choroid plexus cells (CP) cultures in the presence or absence of aphidicolin. (B) Histograms showing the DNA content of CP cells with or without Aphidicolin (5 µg/ml for 24 hours). The DNA content was measured by 7AAD staining and flow-cytometry analysis and provides an indication of the cell cycle. The x and y axis represent the relative DNA content and the cell counts. (C) Graph showing the transduction efficiency (expressed as fluorescence forming foci/ml) of JS-eGFP in proliferating or mitotic arrested CP as described in Materials and Methods.

Discussion

In this study we have investigated the pathogenesis of a unique virus-induced lung adenocarcinoma and obtained data that have a broad significance in pulmonary biology, carcinogenesis and retroviral pathogenesis. Most adenocarcinomas in humans display cells expressing type 2 pneumocytes or Clara cell markers but it is not completely clear whether the neoplasm arises from a stem cell that is able to differentiate into both cell types, or from a committed progenitor or from the fully differentiated cell compartments [74]. In this study, we identified the target cells of JSRV infection and transformation in vivo as proliferating cells of the type 2 pneumocytes lineage (SP-C+/Ki67+, LAPC). In addition, we showed that the age-related susceptibility to experimental OPA induction is directly related to the abundance of LAPCs. Importantly, induction of mild injury to the respiratory epithelium increased dramatically the number of LAPCs in adult sheep and rendered these animals susceptible to JSRV infection and transformation. We have not found evidence that CC10+/Ki67+ cells are infected and transformed by JSRV. Furthermore, we found that the CC10+ cells that are found in a proportion of late stages OPA tumours are not expressing JSRV proteins and may therefore not be true tumour cells, at least in the cases we examined.

Our data provide important consideration for pulmonary biology and carcinogenesis. We infer from our study that at least in sheep, type 2 pneumocytes and Clara cells have two distinct populations of proliferating progenitor cells committed to the alveolar and the bronchiolar lineages. From this study, we cannot determine whether the LAPCs are progenitor committed solely to type 2 or type 1 pneumocytes. We showed that lung adenocarcinoma can originate from an alveolar proliferating cell of the alveolar lineage, rather than from a bronchioalveolar stem cell postulated to originate both type 2 pneumocytes and Clara cells. Studies in mice have identified a population of putative stem cells that are both SP-C+ and CC10+ (bronchioalveolar stem cells, BASCs) located at the bronchioalveolar duct junction [43]. Based on in vitro analysis, BASCs were hypothesised to give rise to Clara cells, alveolar type 2 cells and be the cell originating lung adenocarcinoma [43]. On the other hand, studies using genetic lineage-labelling experiments in mice, supported a model where bronchioli and alveoli are maintained and repaired distinctively by Clara cells and LAPCs respectively [44], [75]. The presence of BASCs in humans has not been confirmed and in general the biological relevance of BASCs is object of debate [44][45]. In our study, by confocal microscopy, we have not been able to detect SP-C+/CC10+ in sheep while we were able to detect cells with this phenotype in mice (Fig. S1). We cannot rule out the presence of a rare bronchioalveolar stem cell (SP-C+/CC10+) able to differentiate in both type 2 pneumocytes and Clara cell progenitors in sheep. We also cannot rule out the presence in sheep of phenotypically uncharacterized pulmonary stem cells. However, if these cells exist in the sheep, they are very rare and unlike LAPCs they do not appear to play a major role in OPA. Interestingly, from the anatomical and histological point of view the human lungs are more comparable to the sheep lungs as opposed to the mice lungs [76][77].

We showed with experiments in vitro that JSRV, similarly to other retroviruses, infects preferentially cells in active mitosis. These experiments provide a mechanistic explanation to the observation that JSRV infects readily LAPCs but not mature type 2 pneumocytes.

As mentioned before, JSRV is a unique oncogenic virus as it possesses the viral Env (a structural protein) that behaves as a functional dominant oncoprotein both in vitro and in vivo. In general, viral oncoproteins are non structural proteins whose expression is not linked to productive infection. It would be detrimental from an evolutionary point of view of the virus, to have productive viral infection and carcinogenesis as strictly mutually dependent events (viral replication would in this case lead to the death of the infected host). Onset of lung adenocarcinoma in JSRV-infected animals could therefore be viewed as either “accidental” (similarly to other retrovirus-induced tumors) or “essential” in order to allow virus spread among susceptible hosts. Although these two alternative hypotheses are not necessarily mutually exclusive, the data obtained in this study and accumulated over the years on JSRV/OPA, strongly suggest that tumor induction plays an important part in the evolutionary strategies used by the virus to persist in the sheep population. In previous studies we have shown that development of OPA in the field occurs only in a minority of the JSRV-infected sheep [39]. On the other hand, animals with OPA produce lung secretions containing abundant amounts of infectious JSRV particles that pour freely from the nostrils of the affected sheep [41], [78][79]. The data from this paper strongly suggests that clinical OPA develops in natural conditions as a result of viral infection only when LAPCs are available to the virus: in young lambs during post-natal development or in the presence of an injury to the bronchioalveolar epithelium. Importantly, as mentioned in the introduction, JSRV proteins are detected readily only in the tumour cells of OPA affected animals (and in the LAPCs as shown in this study) [38] although low levels of virus infection and protein expression are detectable in cells of the lymphoreticular system of animals with or without clinical OPA. We and others have shown that the JSRV LTRs are the main determinants regulating the tight cell-specific expression pattern displayed by this virus. The JSRV LTRs contains lung-specific enhancer binding motifs that are preferentially active in cell lines derived from transformed type 2 pneumocytes [80][83]. In addition, in transgenic mice, reporter gene expression driven by the JSRV LTR has been detected specifically in type 2 pneumocytes [84]. Thus, JSRV-host equilibrium has been reached by a combination of factors. JSRV has evolved a structural protein that is a powerful oncoprotein but only when expressed at high levels in the LAPCs, which are relatively rare cells in the adult healthy sheep. Therefore, JSRV has a limited window of opportunity to infect the target cells of the host that allow high level of viral expression (and that can be consequently transformed). At the same time, onset of lung adenocarcinoma in a minority of the infected animals allows an amplification of the cells that can produce infectious virus and therefore it is a likely evolutionary mechanism that helps JSRV to persist in the population.

It is important to note that in natural conditions, sheep with OPA present consistently a variety of other parasitic, bacterial or viral infections [9]. Classically, these infections were considered as “secondary” to JSRV infection. We suggest instead that in the adult, the induction of an injury to the respiratory epithelium by various pathogens substantially increases the number of LAPCs and renders adult sheep susceptible to JSRV-induced transformation, similarly to what we have shown experimentally in this study with the pneumotoxicant 3MI. Thus, inflammation induced by different pathogens is the “primary” event for OPA induction. It is feasible that in animals already infected with JSRV the virus present in lymphoreticular cells is able to spread to injured tissues where it can infect and transform alveolar progenitor cells actively involved in repairing the epithelium.

In conclusion, this work provided unique insights into pulmonary physiology, lung cancer, and retrovirus pathogenesis and is another telling example where viruses have helped us to understand fundamental aspects of host biology.

Supporting Information

Attachment 1


Zdroje

1. CoffinJMHughesSHVarmusHE 1997 Retroviruses New York Cold Spring Harbor Laboratory Press 843

2. BanerjeePCrawfordLSamuelsonEFeuerG 2010 Hematopoietic stem cells and retroviral infection. Retrovirology 7 8

3. ClarkeMFDickJEDirksPBEavesCJJamiesonCH 2006 Cancer stem cells–perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 66 9339 9344

4. ReyaTMorrisonSJClarkeMFWeissmanIL 2001 Stem cells, cancer, and cancer stem cells. Nature 414 105 111

5. HillRP 2006 Identifying cancer stem cells in solid tumors: case not proven. Cancer Res 66 1891 1895; discussion 1890

6. VisvaderJELindemanGJ 2008 Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 8 755 768

7. ZhouBBZhangHDamelinMGelesKGGrindleyJC 2009 Tumour-initiating cells: challenges and opportunities for anticancer drug discovery. Nat Rev Drug Discov 8 806 823

8. RosenbergNJolicoeurP 1997 Retroviral pathogenesis. CoffinJMHughesSVarmusHE Retroviruses New York Cold Spring Harbor laboratory Press 475585

9. FanH 2003 Jaagsiekte sheep retrovirus and lung cancer Berlin Springer-Verlag

10. PalmariniM 2007 A veterinary twist on pathogen biology. PLoS Pathog 3 e12

11. PalmariniMSharpJMDe las HerasMFanH 1999 Jaagsiekte sheep retrovirus is necessary and sufficient to induce a contagious lung cancer in sheep. J Virol 73 6964 6972

12. PalmariniMFanH 2001 Retrovirus-induced ovine pulmonary adenocarcinoma, an animal model for lung cancer. J Natl Cancer Inst 93 1603 1614

13. LiuSLMillerAD 2007 Oncogenic transformation by the jaagsiekte sheep retrovirus envelope protein. Oncogene 26 789 801

14. AllenTESherrillKJCrispellSMPerrottMRCarlsonJO 2002 The jaagsiekte sheep retrovirus envelope gene induces transformation of the avian fibroblast cell line DF-1 but does not require a conserved SH2 binding domain. J Gen Virol 83 2733 2742

15. MaedaNPalmariniMMurgiaCFanH 2001 Direct transformation of rodent fibroblasts by jaagsiekte sheep retrovirus DNA. Proc Natl Acad Sci U S A 98 4449 4454

16. RaiSKDuhFMVigdorovichVDanilkovitch-MiagkovaALermanMI 2001 Candidate tumor suppressor HYAL2 is a glycosylphosphatidylinositol (GPI)-anchored cell-surface receptor for jaagsiekte sheep retrovirus, the envelope protein of which mediates oncogenic transformation. Proc Natl Acad Sci U S A 98 4443 4448

17. LiuSLDuhFMLermanMIMillerAD 2003 Role of virus receptor Hyal2 in oncogenic transformation of rodent fibroblasts by sheep betaretrovirus env proteins. J Virol 77 2850 2858

18. LiuSLMillerAD 2005 Transformation of madin-darby canine kidney epithelial cells by sheep retrovirus envelope proteins. J Virol 79 927 933

19. MaedaNInoshimaYFrumanDABrachmannSMFanH 2003 Transformation of mouse fibrobalsts by jaagsiekte sheep retrovirus envelope does not require phosphatidylinositol 3-kinase. J Virol 77 9951 9959

20. PalmariniMMaedaNMurgiaCDe-FrajaCHofacreA 2001 A phosphatidylinositol 3-kinase docking site in the cytoplasmic tail of the Jaagsiekte sheep retrovirus transmembrane protein is essential for envelope-induced transformation of NIH 3T3 cells. J Virol 75 11002 11009

21. ZavalaGPrettoCChowYHJonesLAlbertiA 2003 Relevance of Akt phosphorylation in cell transformation induced by Jaagsiekte sheep retrovirus. Virology 312 95 105

22. JohnsonCSandersKFanH 2010 Jaagsiekte sheep retrovirus transformation in Madin-Darby canine kidney epithelial cell three-dimensional culture. J Virol 84 5379 5390

23. CaporaleMCousensCCentoramePPinoniCDe las HerasM 2006 Expression of the Jaagsiekte sheep retrovirus envelope glycoproteins is sufficient to induce lung tumor in sheep. J Virol 80 8030 8037

24. WoottonSKHalbertCLMillerAD 2005 Sheep retrovirus structural protein induces lung tumours. Nature 434 904 907

25. MaedaNFuWOrtinAde las HerasMFanH 2005 Roles of the Ras-MEK-mitogen-activated protein kinase and phosphatidylinositol 3-kinase-Akt-mTOR pathways in Jaagsiekte sheep retrovirus-induced transformation of rodent fibroblast and epithelial cell lines. J Virol 79 4440 4450

26. LiuSLLermanMIMillerAD 2003 Putative phosphatidylinositol 3-kinase (PI3K) binding motifs in ovine betaretrovirus Env proteins are not essential for rodent fibroblast transformation and PI3K/Akt activation. J Virol 77 7924 7935

27. De Las HerasMOrtinABenitoASummersCFerrerLM 2006 In-situ demonstration of mitogen-activated protein kinase Erk 1/2 signalling pathway in contagious respiratory tumours of sheep and goats. J Comp Pathol 135 1 10

28. SharpJMAngusKWGrayEWScottFM 1983 Rapid transmission of sheep pulmonary adenomatosis (jaagsiekte) in young lambs. Brief report. Arch Virol 78 89 95

29. SalvatoriDGonzalezLDewarPCousensCde las HerasM 2004 Successful induction of ovine pulmonary adenocarcinoma in lambs of different ages and detection of viraemia during the preclinical period. J Gen Virol 85 3319 3324

30. HollandMJPalmariniMGarcia-GotiMGonzalezLMcKendrickI 1999 Jaagsiekte retrovirus is widely distributed both in T and B lymphocytes and in mononuclear phagocytes of sheep with naturally and experimentally acquired pulmonary adenomatosis. J Virol 73 4004 4008

31. PalmariniMHollandMJCousensCDalzielRGSharpJM 1996 Jaagsiekte retrovirus establishes a disseminated infection of the lymphoid tissues of sheep affected by pulmonary adenomatosis. J Gen Virol 77 2991 2998

32. PalmariniMSharpJMLeeCFanH 1999 In vitro infection of ovine cell lines by jaagsiekte sheep retrovirus (JSRV). J Virol 73 10070 10078

33. RaiSKDeMartiniJCMillerAD 2000 Retrovirus vectors bearing jaagsiekte sheep retrovirus Env transduce human cells by using a new receptor localized to chromosome 3p21.3. J Virol 74 4698 4704

34. ArnaudFCaporaleMVarelaMBiekRChessaB 2007 A paradigm for virus-host coevolution: sequential counter-adaptations between endogenous and exogenous retroviruses. PLoS Pathog 3 e170

35. ArnaudFVarelaMSpencerTEPalmariniM 2008 Coevolution of endogenous Betaretroviruses of sheep and their host. Cell Mol Life Sci 65 3422 3432

36. OrtinAMinguijonEDewarPGarciaMFerrerLM 1998 Lack of a specific immune response against a recombinant capsid protein of Jaagsiekte sheep retrovirus in sheep and goats naturally affected by enzootic nasal tumour or sheep pulmonary adenomatosis. Vet Immunol Immunopathol 61 229 237

37. ChessaBPereiraFArnaudFAmorimAGoyacheF 2009 Revealing the history of sheep domestication using retrovirus integrations. Science 324 532 536

38. PalmariniMDewarPDe las HerasMInglisNFDalzielRG 1995 Epithelial tumour cells in the lungs of sheep with pulmonary adenomatosis are major sites of replication for Jaagsiekte retrovirus. J Gen Virol 76 2731 2737

39. CaporaleMCentoramePGiovanniniASacchiniFDi VenturaM 2005 Infection of lung epithelial cells and induction of pulmonary adenocarcinoma is not the most common outcome of naturally occurring JSRV infection during the commercial lifespan of sheep. Virology 338 144 153

40. PlattJAKraipowichNVillafaneFDeMartiniJC 2002 Alveolar type II cells expressing jaagsiekte sheep retrovirus capsid protein and surfactant proteins are the predominant neoplastic cell type in ovine pulmonary adenocarcinoma. Vet Pathol 39 341 352

41. De las HerasMGonzalezLSharpJM 2003 Pathology of ovine pulmonary adenocarcinoma. Curr Top Microbiol Immunol 275 25 54

42. BeytutESozmenMErginsoyS 2009 Immunohistochemical detection of pulmonary surfactant proteins and retroviral antigens in the lungs of sheep with pulmonary adenomatosis. J Comp Pathol 140 43 53

43. KimCFJacksonELWoolfendenAELawrenceSBabarI 2005 Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121 823 835

44. RawlinsELOkuboTXueYBrassDMAutenRL 2009 The role of Scgb1a1+ Clara cells in the long-term maintenance and repair of lung airway, but not alveolar, epithelium. Cell Stem Cell 4 525 534

45. GiangrecoAArwertENRosewellIRSnyderJWattFM 2009 Stem cells are dispensable for lung homeostasis but restore airways after injury. Proc Natl Acad Sci U S A 106 9286 9291

46. CaporaleMArnaudFMuraMGolderMMurgiaC 2009 The signal peptide of a simple retrovirus envelope functions as a posttranscriptional regulator of viral gene expression. J Virol 83 4591 4604

47. QuadeK 1979 Transformation of mammalian cells by avian myelocytomatosis virus and avian erythroblastosis virus. Virology 98 461 465

48. PalmariniMCousensCDalzielRGBaiJStedmanK 1996 The exogenous form of Jaagsiekte retrovirus is specifically associated with a contagious lung cancer of sheep. J Virol 70 1618 1623

49. WoottonSKMetzgerMJHudkinsKLAlpersCEYorkD 2006 Lung cancer induced in mice by the envelope protein of jaagsiekte sheep retrovirus (JSRV) closely resembles lung cancer in sheep infected with JSRV. Retrovirology 3 94

50. DonelloJELoebJEHopeTJ 1998 Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element. J Virol 72 5085 5092

51. SchwenterFDeglonNAebischerP 2003 Optimization of human erythropoietin secretion from MLV-infected human primary fibroblasts used for encapsulated cell therapy. J Gene Med 5 246 257

52. BrayMPrasadSDubayJWHunterEJeangKT 1994 A small element from the Mason-Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent. Proc Natl Acad Sci U S A 91 1256 1260

53. ZolotukhinASValentinAPavlakisGNFelberBK 1994 Continuous propagation of RRE(-) and Rev(-)RRE(-) human immunodeficiency virus type 1 molecular clones containing a cis-acting element of simian retrovirus type 1 in human peripheral blood lymphocytes. J Virol 68 7944 7952

54. MillerADChenF 1996 Retrovirus packaging cells based on 10A1 murine leukemia virus for production of vectors that use multiple receptors for cell entry. J Virol 70 5564 5571

55. ZaffranSAstierMGratecosDSemerivaM 1997 The held out wings (how) Drosophila gene encodes a putative RNA-binding protein involved in the control of muscular and cardiac activity. Development 124 2087 2098

56. NaldiniLBlomerUGallayPOryDMulliganR 1996 In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272 263 267

57. BahnsonABDuniganJTBaysalBEMohneyTAtchisonRW 1995 Centrifugal enhancement of retroviral mediated gene transfer. J Virol Methods 54 131 143

58. O'DohertyUSwiggardWJMalimMH 2000 Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. J Virol 74 10074 10080

59. DeMartiniJCRosadioRHSharpJMRussellHILairmoreMD 1987 Experimental coinduction of type D retrovirus-associated pulmonary carcinoma and lentivirus-associated lymphoid interstitial pneumonia in lambs. J Natl Cancer Inst 79 167 177

60. NisbetDIMackayJMSmithWGrayEW 1971 Ultrastructure of sheep pulmonary adenomatosis (Jaagsiekte). J Pathol 103 157 162

61. PayneALVerwoerdDW 1984 A scanning and transmission electron microscopy study of jaagsiekte lesions. Onderstepoort J Vet Res 51 1 13

62. PerkKHodINobelTA 1971 Pulmonary adenomatosis of sheep (jaagsiekte). I. Ultrastructure of the tumor. J Natl Cancer Inst 46 525 537

63. PlopperCGHydeDMBuckpittAR 1997 Clara cells. CrystalRGWestJBWeibelERBarnesPJ The Lung: Scientific Foundations Philadelphia Lippincott-Raven 517 533

64. WhitsettJAGlasserSW 1998 Regulation of surfactant protein gene transcription. Biochim Biophys Acta 1408 303 311

65. VerwoerdDWWilliamsonALDe VilliersEM 1980 Aetiology of jaagsiekte: transmission by means of subcellular fractions and evidence for the involvement of a retrovirus. Onderstepoort J Vet Res 47 275 280

66. KauffmanSL 1980 Cell proliferation in the mammalian lung. Int Rev Exp Pathol 22 131 191

67. ZeltnerTBBurriPH 1987 The postnatal development and growth of the human lung. II. Morphology. Respir Physiol 67 269 282

68. ZeltnerTBCaduffJHGehrPPfenningerJBurriPH 1987 The postnatal development and growth of the human lung. I. Morphometry. Respir Physiol 67 247 267

69. KubbutatMHKeyGDuchrowMSchluterCFladHD 1994 Epitope analysis of antibodies recognising the cell proliferation associated nuclear antigen previously defined by the antibody Ki-67 (Ki-67 protein). J Clin Pathol 47 524 528

70. BradleyBJCarlsonJRDickinsonEO 1978 3-methylindole-induced pulmonary edema and emphysema in sheep. Am J Vet Res 39 1355 1358

71. LewisPFEmermanM 1994 Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J Virol 68 510 516

72. MillerDGAdamMAMillerAD 1990 Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 10 4239 4242

73. RoeTReynoldsTCYuGBrownPO 1993 Integration of murine leukemia virus DNA depends on mitosis. Embo J 12 2099 2108

74. Rosai JaSLH 1995 Conditional Clara cell ablation reveals a self-renewing progenitor function of pulmonary neuroendocrine cells Atlas of Tumor Pathology Washington DC Armed Forces Institute of Pathology

75. RawlinsELOkuboTQueJXueYClarkC 2008 Epithelial stem/progenitor cells in lung postnatal growth, maintenance, and repair. Cold Spring Harb Symp Quant Biol 73 291 295

76. ScheerlinckJPSnibsonKJBowlesVMSuttonP 2008 Biomedical applications of sheep models: from asthma to vaccines. Trends Biotechnol 26 259 266

77. HarrisA 1997 Towards an ovine model of cystic fibrosis. Hum Mol Genet 6 2191 2194

78. SharpJMDeMartiniJC 2003 Natural history of JSRV in sheep. Curr Top Microbiol Immunol 275 55 79

79. CousensCThonurLImlachSCrawfordJSalesJ 2009 Jaagsiekte sheep retrovirus is present at high concentration in lung fluid produced by ovine pulmonary adenocarcinoma-affected sheep and can survive for several weeks at ambient temperatures. Res Vet Sci 87 154 156

80. McGee-EstradaKFanH 2006 In Vivo and In Vitro Analysis of Factor Binding Sites in Jaagsiekte Sheep Retrovirus Long Terminal Repeat Enhancer Sequences: Roles of HNF-3, NF-I, and C/EBP for Activity in Lung Epithelial Cells. J Virol 80 332 341

81. McGee-EstradaKPalmariniMFanH 2002 HNF-3ß is a critical factor for the expression of the Jaagsiekte sheep retrovirus (JSRV) long terminal repeat in type II pneumocytes but not in clara cells. Virology 292 87 97

82. McGee-EstradaKPalmariniMHallwirthCFanH 2005 A Moloney murine leukemia virus driven by the Jaagsiekte sheep retrovirus enhancers shows enhanced specificity for infectivity in lung epithelial cells. Virus Genes 31 257 263

83. PalmariniMDattaSOmidRMurgiaCFanH 2000 The long terminal repeats of Jaagsiekte sheep retrovirus (JSRV) are preferentially active in type II pneumocytes. J Virol 74 5776 5787

84. DakessianRMFanH 2008 Specific in vivo expression in type II pneumocytes of the Jaagsiekte sheep retrovirus long terminal repeat in transgenic mice. Virology 372 398 408

85. WinkelmannANoackT 2010 The Clara cell: a “Third Reich eponym”? Eur Respir J 36 722 727

Štítky
Hygiena a epidemiologie Infekční lékařství Laboratoř

Článek vyšel v časopise

PLOS Pathogens


2011 Číslo 3

Nejčtenější v tomto čísle

Tomuto tématu se dále věnují…


Kurzy

Zvyšte si kvalifikaci online z pohodlí domova

Minimonografie - vědomostní test
nový kurz

Léčba karcinomu močového měchýře
Autoři:

Imunitní trombocytopenie (ITP)
Autoři: prof. MUDr. Tomáš Kozák, Ph.D., MBA

Léčba bolesti v ordinaci praktického lékaře
Autoři: MUDr. PhDr. Zdeňka Nováková, Ph.D.

Prediabetes
Autoři:

Všechny kurzy
Kurzy Doporučená témata Časopisy
Přihlášení
Zapomenuté heslo

Nemáte účet?  Registrujte se

Zapomenuté heslo

Zadejte e-mailovou adresu se kterou jste vytvářel(a) účet, budou Vám na ni zaslány informace k nastavení nového hesla.

Přihlášení

Nemáte účet?  Registrujte se